Preventive Maintenance and unlimited repair agreement (Silver Support or equal) for three (3) Illumina NextSeq 2000 instruments

The Food and Drug Administration (FDA) is seeking a vendor to provide preventive maintenance and unlimited repair services for three Illumina NextSeq 2000 instruments. The contract will include a base period plus four option years. The vendor will be responsible for replacement of reagents that are lost from failed runs. The FDA has provided answers to questions submitted in response to the solicitation, including information about the reagent kits used on the machines. • The contract includes a base period plus four option years. • The vendor will be responsible for preventive maintenance and unlimited repairs. • The vendor will be responsible for replacement of reagents that are lost from failed runs. • The FDA has provided information about the reagent kits used on the machines.